Alvin Luk is the founder of Neurophth Therapeutics. Neurophth Therapeutics has raised $125M in total funding. Latest round: Series C+.
Alvin Luk is the founder and scientific leader of Neurophth Therapeutics, a biotech company focused on developing gene therapies for Leber hereditary optic neuropathy (LHON). He has presented clinical data on the safety and efficacy of their rAAV2-ND4 gene therapy and oversees strategic partnerships.
Full founder directory · Investor directory · Company funding database · Fundraising library